arrow
D

David Nanchen

center for primary care and public health
H指数:32
被引数:4,784

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

One-Year Systolic Blood Pressure and Subsequent Cardiovascular Outcomes After Acute Coronary Syndrome: Insights from a Swiss Prospective Cohort

急性冠状动脉综合征后一年的收缩压及后续心血管结局:来自瑞士前瞻性队列研究的启示

2026-10-110
OAAI
Interleukin-8 and other neutrophil-related biomarkers are associated with 1-year mortality in patients with acute myocardial infarction

白细胞介素-8和其他中性粒细胞相关生物标志物与急性心肌梗死患者1年死亡率相关

2026-09-220
OAAI
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

全球脂质门诊:优化组织与资金筹措的协调与指导。欧洲动脉粥样硬化学会在55个国家及500多家脂质门诊达成的共识声明

2026-05-250
OAAI
Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease

肠道菌群衍生的咪唑丙酸盐可预测冠状动脉疾病患者的心血管代谢风险

2025-08-011
OA
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes

教育水平、临床结局及护理质量:一项来自瑞士急性冠状动脉综合征患者队列的研究

2025-07-260
OAAI
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort

左心室射血分数保留或轻度降低的急性冠脉综合征后停用 β 受体阻滞剂的安全性: 来自真实世界队列的目标试验仿真

2024-10-260
PRE
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

联合治疗与改善低密度脂蛋白胆固醇管理相关: 欧洲观察性圣托里尼研究的1年随访结果

2024-06-112
OA